Digital Sponsored Adapting the future of DTx clinical trials – Woebot Health Following DTx West 2023 in San Mateo, California, back in February, Woebot Health’s chief clinical officer Athena Robinson spoke with pharmaphorum about the conversations had at the event,
Digital The (inevitable) digital transformation of Medical Affairs Drawing on a recent report, Natalie Yeadon walks us through the digital transformation in Medical Affairs over the last few years.
Digital Exploring the potential of the metaverse in healthcare Immersive experiences could be impactful and valuable to life sciences and healthcare.
Digital AI technology: A game-changer for rare disease diagnosis AI technology isn’t designed to replace clinicians - its function is to help them.
Digital DTx and the case for fit-for-purpose evidentiary standard DTx deliver evidence-based therapeutic interventions driven by high-quality software programs
Digital The connected care horizon in 2023 Some connected care trends expected include digital therapeutics & remote patient monitoring.
News Merck rare tumour drug Ezmekly backed for NHS use Merck's drug for tumours associated with rare disease neurofibromatosis type 1, Ezmekly, has been cleared for NHS use in children as young as two.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.